Good evening :)
JFL Life Sciences Ltd

JFL Life Sciences Ltd

JFLLIFE Share Price

NSE
₹10.455.00% (-0.55)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹34 cr, stock is ranked 4,006

High Risk

Stock is 4.55x as volatile as Nifty

JFLLIFE Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Avg

Financials growth has been moderate for a few years

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹34 cr, stock is ranked 4,006

High Risk

Stock is 4.55x as volatile as Nifty

JFLLIFE Performance & Key Metrics

JFLLIFE Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
7.140.87—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.715.790.58%

JFLLIFE Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

JFLLIFE Company Profile

JFL Life Sciences Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing of pharmaceutical products

JFLLIFE Similar Stocks (Peers)

Compare with peers Compare with peers 

JFLLIFE Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
38.47
38.47
1Y Return
10.56%
10.56%
Buy Reco %
94.29
94.29
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
77.37
77.37
1Y Return
47.65%
47.65%
Buy Reco %
81.48
81.48
Cipla Ltd
CIPLA
PE Ratio
20.71
20.71
1Y Return
3.97%
3.97%
Buy Reco %
54.84
54.84
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
19.06
19.06
1Y Return
15.61%
15.61%
Buy Reco %
48.39
48.39
Lupin Ltd
LUPIN
PE Ratio
32.19
32.19
1Y Return
18.34%
18.34%
Buy Reco %
72.22
72.22
Compare with Peers

JFLLIFE Forecast

JFLLIFE Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

JFLLIFE

JFLLIFE

Income

Balance Sheet

Cash Flow

JFLLIFE Income Statement

JFLLIFE Income Statement

Loading...

Quarterdec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025
Total Revenue6.0221.729.5539.5121.2511.7311.5929.9226.85
Operating & Other expensessubtract4.9920.166.4937.1019.9010.369.6526.9923.49
Depreciation/Amortizationsubtract0.120.110.240.240.160.360.260.270.27
Interest & Other Itemssubtract-0.240.090.260.270.200.330.240.440.38
Taxes & Other Itemssubtract0.020.180.650.440.250.600.690.240.69
EPS0.340.120.581.320.220.030.230.600.61
See Costs

EPS in ₹. Other numbers in ₹ cr

JFLLIFE Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

JFLLIFE Stock Peers

JFLLIFE Past Performance & Peer Comparison

JFLLIFE Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
JFL Life Sciences Ltd8.290.87—
Sun Pharmaceutical Industries Ltd38.475.800.91%
Torrent Pharmaceuticals Ltd77.3719.480.73%
Cipla Ltd20.713.491.18%

JFLLIFE Stock Price Comparison

Compare JFLLIFE with any stock or ETF
Compare JFLLIFE with any stock or ETF
JFLLIFE
Loading...

JFLLIFE Holdings

JFLLIFE Shareholdings

JFLLIFE Promoter Holdings Trend

JFLLIFE Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

JFLLIFE Institutional Holdings Trend

JFLLIFE Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

JFLLIFE Shareholding Pattern

JFLLIFE Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding67.47%0.00%0.00%0.00%32.53%

Mar 2025

Jun 2025

Sep 2025

Dec 2025

JFLLIFE Shareholding History

JFLLIFE Shareholding History

MarSepMarJunSepDec '250.00%0.00%0.00%0.00%0.00%0.00%

JFLLIFE Insider Trades & Bulk Stock Deals

JFLLIFE Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing JFLLIFE stock

smallcases containing JFLLIFE stock

Looks like this stock is not in any smallcase yet.

JFLLIFE Events

JFLLIFE Events

JFLLIFE Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

JFLLIFE Dividend Trend

No dividend trend available

JFLLIFE Upcoming Dividends

JFLLIFE Upcoming Dividends

No upcoming dividends are available

JFLLIFE Past Dividends

JFLLIFE Past Dividends

Cash Dividend

Ex DateEx DateSep 13, 2024

Final
Final | Div/Share: ₹0.25

Dividend/Share

₹0.25

Ex DateEx Date

Sep 13, 2024

JFLLIFE Stock News & Opinions

JFLLIFE Stock News & Opinions

Corporate
JFL Life Sciences to hold board meeting

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 4 March 2026.Powered by Capital Market - Live

3 days agoCapital Market - Live
Earnings
JFL Life Sciences standalone net profit rises 172.97% in the December 2025 quarter

Net profit of JFL Life Sciences rose 172.97% to Rs 2.02 crore in the quarter ended December 2025 as against Rs 0.74 crore during the previous quarter ended December 2024. Sales rose 26.31% to Rs 26.84 crore in the quarter ended December 2025 as against Rs 21.25 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales26.8421.25 26 OPM %12.486.35 - PBDT2.981.15 159 PBT2.710.99 174 NP2.020.74 173 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
JFL Life Sciences schedules board meeting

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
JFL Life Sciences standalone net profit rises 35.86% in the September 2025 quarter

Net profit of JFL Life Sciences rose 35.86% to Rs 1.97 crore in the quarter ended September 2025 as against Rs 1.45 crore during the previous quarter ended September 2024. Sales declined 24.30% to Rs 29.91 crore in the quarter ended September 2025 as against Rs 39.51 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales29.9139.51 -24 OPM %9.736.07 - PBDT2.482.13 16 PBT2.211.89 17 NP1.971.45 36 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
JFL Life Sciences to table results

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
JFL Life Sciences schedules EGM

JFL Life Sciences announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 October 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
JFL Life Sciences to hold AGM

JFL Life Sciences announced that the 15th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
JFL Life Sciences announces board meeting date

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 1 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
JFL Life Sciences standalone net profit declines 60.73% in the June 2025 quarter

Net profit of JFL Life Sciences declined 60.73% to Rs 0.75 crore in the quarter ended June 2025 as against Rs 1.91 crore during the previous quarter ended June 2024. Sales rose 21.49% to Rs 11.59 crore in the quarter ended June 2025 as against Rs 9.54 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales11.599.54 21 OPM %16.7432.08 - PBDT1.702.80 -39 PBT1.442.56 -44 NP0.751.91 -61 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
JFL Life Sciences to conduct board meeting

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 11 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of JFL Life Sciences Ltd (JFLLIFE) today?

    The share price of JFLLIFE as on 2nd March 2026 is ₹10.45. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on JFL Life Sciences Ltd (JFLLIFE) share?

    The past returns of JFL Life Sciences Ltd (JFLLIFE) share are
    • Past 1 week: 0.48%
    • Past 1 month: N/A%
    • Past 3 months: -12.92%
    • Past 6 months: -27.18%
    • Past 1 year: -49.39%
    • Past 3 years: -5.26%
    • Past 5 years: -52.86%

  3. What are the peers or stocks similar to JFL Life Sciences Ltd (JFLLIFE)?

    The peers or stocks similar to JFL Life Sciences Ltd (JFLLIFE) include:

  4. What is the market cap of JFL Life Sciences Ltd (JFLLIFE) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of JFL Life Sciences Ltd (JFLLIFE) is ₹34.48 Cr as of 2nd March 2026.

  5. What is the 52 week high and low of JFL Life Sciences Ltd (JFLLIFE) share?

    The 52-week high of JFL Life Sciences Ltd (JFLLIFE) is ₹22.20 and the 52-week low is ₹10.

  6. What is the PE and PB ratio of JFL Life Sciences Ltd (JFLLIFE) stock?

    The P/E (price-to-earnings) ratio of JFL Life Sciences Ltd (JFLLIFE) is 8.29. The P/B (price-to-book) ratio is 0.87.

  7. Which sector does JFL Life Sciences Ltd (JFLLIFE) belong to?

    JFL Life Sciences Ltd (JFLLIFE) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy JFL Life Sciences Ltd (JFLLIFE) shares?

    You can directly buy JFL Life Sciences Ltd (JFLLIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.